175 related articles for article (PubMed ID: 23519332)
1. Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease.
Shiue LH; Alousi AM; Wei C; Hosing CM; Duvic M; Ni X
J Invest Dermatol; 2013 Aug; 133(8):2098-100. PubMed ID: 23519332
[No Abstract] [Full Text] [Related]
2. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.
Rao V; Saunes M; Jørstad S; Moen T
Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201
[TBL] [Abstract][Full Text] [Related]
4. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
5. CD209
Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis: the Hellenic experience.
Dervenoulas J; Tsirigotis P
Transfus Apher Sci; 2012 Apr; 46(2):169. PubMed ID: 22361574
[No Abstract] [Full Text] [Related]
8. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
10. Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.
Bredberg A; Jonsson S; Lindblom A; Björk P
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):113-9. PubMed ID: 17598863
[TBL] [Abstract][Full Text] [Related]
11. T cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease.
French LE; Rook AH
Transfus Apher Sci; 2002 Jun; 26(3):191-6. PubMed ID: 12126205
[TBL] [Abstract][Full Text] [Related]
12. [Extracorporeal photopheresis].
Hsieh A; Cortés B
Rev Med Suisse; 2018 Mar; 14(600):699-702. PubMed ID: 29589657
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease.
Schneiderman J
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):639-644. PubMed ID: 29222315
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Fimiani M; Di Renzo M; Rubegni P
Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis: how, when, and why.
Ward DM
J Clin Apher; 2011; 26(5):276-85. PubMed ID: 21898572
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of extracorporeal photopheresis.
Girardi M
Clin Adv Hematol Oncol; 2006 May; 4(5):349-50. PubMed ID: 16728944
[No Abstract] [Full Text] [Related]
18. The North American experience with photopheresis.
Zic JA; Miller JL; Stricklin GP; King LE
Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
[TBL] [Abstract][Full Text] [Related]
19. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ; Lonial S; Renfroe HM; Roback JD; Tighiouart M; Vaughn L; Waller EK
Transfusion; 2010 Nov; 50(11):2424-31. PubMed ID: 20529004
[TBL] [Abstract][Full Text] [Related]
20. Current clinical applications of extracorporeal photochemotherapy.
Capuano M; Sommese L; Pignalosa O; Parente D; Fabbricini R; Nicoletti GF; De Pascale MR; Schiano C; Napoli C
Ther Apher Dial; 2015 Apr; 19(2):103-10. PubMed ID: 25363837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
